A Study of AL102 in Patients With Progressing Desmoid Tumors
Trial ID or NCT#
NCT04871282
Status
NOT RECRUITING
Purpose
The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.
Official Title
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
Eligibility Criteria
Ages Eligible for Study: Older than 12 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Nam Quoc Bui
Medical oncologist,
Sarcoma specialist
Clinical Associate Professor, Medicine - Oncology
Contact us to find out if this trial is right for you.
Contact
Ileana Aguilar Torres
ileanaa@stanford.edu
View on